<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>26026620</identifier>
<setSpec>1578-1275</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Otero Puime, Ángel</dc:author>
<dc:author>Bonis, Julio</dc:author>
<dc:author>Castell Alcalá, María Victoria</dc:author>
<dc:author>de Hoyos-Alonso, María del Canto</dc:author>
<dc:author>Bryant, Verónica</dc:author>
<dc:description xml:lang="en">OBJECTIVE To ascertain the diagnosis associated with specific treatment for dementia in the Primary Care Electronic Clinical Record (PC-ECR) and to analyse the factors associated with the quality of registration. METHODS Descriptive study of patients taking cholinesterase inhibitors or memantine registered in Database for pharmacoepidemiological research in PC (BIFAP) 2011: 24,575 patients between 2002 and 2011. Diagnoses associated with first prescription of these drugs were grouped into 5 categories: "dementia", "memory impairment", "dementia-related diseases", "intercurrent processes" and "convenience codes". We calculated the prevalence of each category by age and sex for each study year (95%CI) and analysed the associations and trend for 2002-2011 using difference in proportions in independent samples and binary logistic regression. RESULTS A code of "dementia" was associated with first prescription in 56.5% (95%CI: 55.8-57.1) of patients. It was higher in women [OR1.09 (95%CI: 1.03-1.15)] and with increasing follow-up time [OR1.07 (95%CI: 1.06-1.08) for each year of follow-up]. "Convenience codes" [16.3% (95%CI: 15.8-16.7)] were coded more frequently in women and in those ≥80 years; "Memory impairment" [12.4% (95%CI: 12.0-12.8)], "related diseases" [4.6% (95%CI: 4.4-4.8)] and "intercurrent processes" [10.3% (95%CI: 9.9-10.6)] were used more in men and in persons &lt;80 years. Between 2002 and 2011 improved the use of "convenience codes". CONCLUSIONS Almost half of the patients taking cholinesterase inhibitors or memantine do not have a diagnosis of dementia registered in their PC-ECR. Registration improves with increasing time of follow-up. Improvements are needed in the PC-ECR, adequate care coordination, and proactive approach to increase the quality of dementia registration.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Infradiagnóstico</dc:subject>
<dc:subject>Anticolinesterásicos</dc:subject>
<dc:subject>Memantine</dc:subject>
<dc:subject>Atención primaria</dc:subject>
<dc:subject>Memantina</dc:subject>
<dc:subject>Quality coding</dc:subject>
<dc:subject>Under-diagnosis</dc:subject>
<dc:subject>Calidad de registro</dc:subject>
<dc:subject>Primary Health Care</dc:subject>
<dc:subject>Cholinesterase inhibitors</dc:subject>
<dc:subject>Demencia</dc:subject>
<dc:subject>Dementia</dc:subject>
<dc:date>2016 Jan </dc:date>
<dc:title xml:lang="es">Calidad del registro del diagnóstico de demencia en atención primaria. La situación en España en el periodo 2002-2011.</dc:title>
<dc:title xml:lang="en">[Quality of registration of dementia diagnosis in primary care: The situation in Spain in 2002-2011].</dc:title>
<dc:publisher>Atencion primaria</dc:publisher>
</metadata>
</record>
</pubmed-document>
